Cyclerion Therapeutics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
CYCN Nasdaq 8731 https://www.cyclerion.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cyclerion Therapeutics Inc

The Petri Dish: Alexion buys Pfizer gene therapies in $1B deal; Peter Hecht's plan to save Cyclerion assets - Aug 3rd, 2023 12:39 am
Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets - Jul 31st, 2023 11:00 am
Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement - Jun 1st, 2023 8:00 pm
Cyclerion Announces Reverse Stock Split - May 15th, 2023 5:00 pm
Cyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company Established By Shareholders, New Investors - May 12th, 2023 6:59 pm
Cyclerion Announces Definitive Agreement for Zagociguat and CY3018 - May 11th, 2023 10:00 pm
Cyclerion Announces Corporate Updates and Q1 2023 Financial Results - May 11th, 2023 10:00 pm
Cyclerion Therapeutics Enters into Exclusive Negotiation Period and Binding Equity Investment Agreement - Apr 3rd, 2023 11:30 am
Cyclerion Therapeutics Receives U.S. FDA Orphan Drug Designation for Zagociguat for the Treatment of Mitochondrial Diseases - Mar 27th, 2023 11:00 am
Cyclerion Reports Corporate Update and Full Year 2022 Financial Results - Mar 22nd, 2023 8:40 pm
Cyclerion Concludes Unsolicited Proposal Is Not in The Best Interest of The Company - Nov 22nd, 2022 12:00 pm
Cyclerion Therapeutics Third Quarter 2022 Earnings: US$0.24 loss per share (vs US$0.26 loss in 3Q 2021) - Nov 9th, 2022 11:34 am
Cyclerion Therapeutics lays off nearly half of workforce - Oct 7th, 2022 6:31 pm
Cyclerion Shares Fall After Reprioritized Pipeline, Workforce Reduction - Oct 6th, 2022 4:46 pm
Cyclerion Announces Mitochondrial Disease-Focused Corporate Strategy - Oct 6th, 2022 12:00 pm